Clinical Study
Twelve-Month Follow-Up of Dexamethasone Implants for Macular Edema from Various Diseases in Vitrectomized and Nonvitrectomized Eyes
Table 6
Baseline and 12-month CRT related to numbers of implants and vitrectomy.
| | Baseline CRT | 12-month CRT | value |
| Number of implants | | | | All eyes | 463 (214–920) | 254 (154–977) | <0.001 | 1 | 418 (244–920) | 279 (196–977) | <0.001 | 2 | 469 (302–746) | 270 (164–634) | 0.002 | 3 | 487 (214–777) | 232 (185–402) | 0.001 | 4 | 733 (510–840) | 242 (168–741) | 0.144 |
| Vitrectomized | | | | No | 421 (243–920) | 265 (194–977) | <0.001 | Yes | 532 (214–840) | 232 (154–741) | <0.001 |
|
|
CRT, central retinal thickness. Wilcoxon test.
|